INTERNATIONAL PATENT: WOOLSEY PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS FOR TREATING ALS WITH A RHO KINASE INHIBITOR BASED ON USE OF NEUROFILAMENT LIGHT CHAIN BIOMARKER"

GENEVA, Oct. 6 -- WOOLSEY PHARMACEUTICALS, INC. (7901 4th Street NSuite 6987St. Petersburg, Florida 33702) filed a patent application (PCT/US2025/021086) for "METHODS FOR TREATING ALS WITH A RHO KINASE INHIBITOR BASED ON USE OF NEUROFILAMENT LIGHT CHAIN BIOMARKER" on Mar 24, 2025. With publication no. WO/2025/207476, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MACALLISTER, Thomas (1201 N Garfield St.#319Arlington, Virginia 22201), JACOBSON, Sven (37 Wall St.#16BNew York, New York 10005)

Abstract: A method of treating...